ORIGINAL ARTICLE

¹ Department of Neonatology and Centre for Clinical Studies, University of Queensland, Mater Health Services, South Brisbane, Queensland, Australia
² Australian Centre for Paediatric Pharmacokinetics, School of Pharmacy, University of Queensland
³ Neonatal Medicine, Royal Prince Alfred Hospital and Centre for Perinatal Health Services Research, University of Sydney, New South Wales, Australia
⁴ Royal Hobart Hospital, Hobart, Tasmania. Australia
⁵ Mercy Hospital for Women, Melbourne, Victoria, Australia

Correspondence to:
Correspondence to:
Vicki Flenady
Centre for Clinical Studies, Mater Health Services, Raymond Terrace, South Brisbane, Queensland, Australia 4101; vflenady{at}mater.org.au

Objective: To compare two dosing regimens for caffeine citrate in the periextubation period for neonates born at less than 30 weeks gestation in terms of successful extubation and adverse effects.

Design: A multicentre, randomised, double blind, clinical trial.

Setting: Four tertiary neonatal units within Australia.

Patients: Infants born less than 30 weeks gestation ventilated for more than 48 hours.

Interventions: Two dosing regimens of caffeine citrate (20 v 5 mg/kg/day) for periextubation management. Treatment started 24 hours before a planned extubation or within six hours of an unplanned extubation.

Main outcome measure: Failure to extubate within 48 hours of caffeine loading or reintubation and ventilation or doxapram within seven days of caffeine loading.

Results: A total of 234 neonates were enrolled. A significant reduction in failure to extubate was shown for the 20 mg/kg/day dosing group (15.0% v 29.8%; relative risk 0.51; 95% confidence interval (CI) 0.31 to 0.85; number needed to treat 7 (95% CI 4 to 24)). A significant difference in duration of mechanical ventilation was shown for infants of less than 28 weeks gestation receiving the high dose of caffeine (mean (SD) days 14.4 (11.1) v 22.1 (17.1); p  =  0.01). No difference in adverse effects was detected in terms of mortality, major neonatal morbidity, death, or severe disability or general quotient at 12 months.

Conclusions: This trial shows short term benefits for a 20 mg/kg/day dosing regimen of caffeine citrate for neonates born at less than 30 weeks gestation in the periextubation period, without evidence of harm in the first year of life.

Keywords: caffeine; preterm; apnoea; extubation

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Fantoms

Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2004 89: F471. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Greenough, A, Prendergast, M (2008). Difficult extubation in low birthweight infants. Arch. Dis. Child. Fetal Neonatal Ed. 93: F242-F245 [Abstract] [Full Text]  
• Natarajan, G., Botica, M.-L., Thomas, R., Aranda, J. V. (2007). Therapeutic Drug Monitoring for Caffeine in Preterm Neonates: An Unnecessary Exercise?. Pediatrics 119: 936-940 [Abstract] [Full Text]  
• Bancalari, E. (2006). Caffeine for Apnea of Prematurity. NEJM 354: 2179-2181 [Full Text]  
• Hoecker, C, Nelle, M, Beedgen, B, Rengelshausen, J, Linderkamp, O (2006). Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 91: F61-F64 [Abstract] [Full Text]